News blog
Akers Biosciences Inc
- BY: Andrew Hore |
- POSTED: 24/11/2009 |
- COMMENTS: Add yours
Legal & General has taken advantage of recent share price weakness to take a stake in Akers Biosciences Inc.
Legal & General has bought 6.8m shares, giving it a 5.96% stake in the diagnostics company.
Southridge Capital Management (Brittany Capital) has cut its stake from 25.94% to 13.79%.
Weak trading at Akers has knocked the share price, although it has started to recover in recent weeks.
At 14.25p a share, Akers is valued at £16.2m.
© 2007 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- 2.4mNumber of messages posted on SocialGo networks
- $38mCost savings generated by ideas from WalMart staff over a two month period
- 19.4m
Number of people passing through Johannesburg Airport in 2007
- News Blog
- All micro news
Synchronica
Mobile messaging technology provider Synchronica, which is the subject of a contested, all-share bid from rival Myriad AG, has signed a letter of intent with TSX Venture Exchange-quoted Intertainment Media.
DCD Media
AIM-quoted Timeweave has bought convertible loan notes in DCD Media that can convert into a 29.9% stake in the TV programmes producer.
James Cropper
Paper and speciality fibres manufacturer James Cropper is investing $3m in a new manufacturing facility in New York State.
TEG Group
Peter Gyllenhammar has taken his stake in TEG Group to 3.2% following the purchase of 500,000 shares.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|